{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7727,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/2xhTjRTbffFuhyz44ItRxybURIjg8_EpVeGf5igfjxU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MTlkYjUwMjQ0YTk2ZGEyYmJmNzljYzhmN2Q5MTY4NC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/1",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/y42P47IRm5hI7pC4GHlwxYQPpCEIX5GINRpaEHVwvOs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MTlkYjUwMjQ0YTk2ZGEyYmJmNzljYzhmN2Q5MTY4NC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/EvUL23a2dLKVK7vXbS6iz_M0lqcfSsrUtyIK256pgOU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MTlkYjUwMjQ0YTk2ZGEyYmJmNzljYzhmN2Q5MTY4NC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/G75FBO-7xbBu0DaOurhNmEJGOhkaj7pX_Sagj1bfF8c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83MTlkYjUwMjQ0YTk2ZGEyYmJmNzljYzhmN2Q5MTY4NC9wMDAxLnBuZw"
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/2",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/3",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-3",
      "loopMatches": [
        {
          "to": 4,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "d79650a2-de98-4743-9328-e51b79de3348",
          "evidence": "The document presents a clear strategy for value creation.",
          "position": 1,
          "objective": "Why is Arbutus Biopharma's approach necessary?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a grid layout to present six distinct value propositions for the company.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/4",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-4",
      "loopMatches": [
        {
          "to": 4,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "d79650a2-de98-4743-9328-e51b79de3348",
          "evidence": "The document presents a clear strategy for value creation.",
          "position": 1,
          "objective": "Why is Arbutus Biopharma's approach necessary?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a standard pharmaceutical pipeline visualization format.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/5",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 5,
          "beatId": "2d0bcfd3-93dd-4169-8361-249835e5745f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Roadmap",
          "beatSlug": null,
          "evidence": "The document outlines a clear pipeline and future milestones.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "context",
      "function": "frame_problem",
      "notes": "The slide uses a four-column layout to structure the disease landscape.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/6",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "Uses a Venn/concentric circle diagram to show the funnel from total infected to diagnosed to treated.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/7",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-7",
      "loopMatches": [
        {
          "to": 8,
          "from": 7,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "638f7144-417a-4d6e-b4c5-08de0273f8f0",
          "evidence": "The document presents a clear problem statement and solution.",
          "position": 0,
          "objective": "What if we could effectively address HBV?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        },
        {
          "to": 7,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "90071096-8742-47da-86c2-14db82c852fd",
          "evidence": "The document highlights the significant unmet medical need.",
          "position": 2,
          "objective": "What are the consequences of not addressing HBV?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 7,
          "from": 7,
          "beatId": "fdd484d0-aa38-4059-a7b0-8277ccde5cde",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem Statement",
          "beatSlug": null,
          "evidence": "The document clearly states the problem of HBV presenting a significant unmet medical need.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-oriented flow diagram to explain the therapeutic strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/8",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-8",
      "loopMatches": [
        {
          "to": 8,
          "from": 7,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "638f7144-417a-4d6e-b4c5-08de0273f8f0",
          "evidence": "The document presents a clear problem statement and solution.",
          "position": 0,
          "objective": "What if we could effectively address HBV?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 8,
          "beatId": "b57cdf9a-4123-4383-978f-604a5f92abd8",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": null,
          "evidence": "The document presents a 3-pronged approach to therapeutic success.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/9",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide highlights the mechanism of action and key benefits of the drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/10",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/11",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 11,
          "beatId": "e153389a-d707-48de-97dd-4aa6c973fe23",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Key Takeaways",
          "beatSlug": null,
          "evidence": "The document highlights key takeaways from clinical trials.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a clinical trial protocol with specific patient counts (n=43, 12, 13, 8, 10) and timeline milestones (weeks 1, 24, 28, 40, 52).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/12",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented at EASL 2024. Includes specific patient counts and percentages for Cohorts A1 and A2.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/13",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 13,
          "beatId": "a03442fb-e554-4013-a27a-a70f868887ac",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The document showcases positive clinical trial results for Imdusiran and AB-101.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented at EASL 2024. LLOQ = 0.05 IU/mL.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/14",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 13,
          "beatId": "a03442fb-e554-4013-a27a-a70f868887ac",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The document showcases positive clinical trial results for Imdusiran and AB-101.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines two parallel study arms involving Imdusiran, VTP-300, NA, and Nivolumab.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/15",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 13,
          "beatId": "a03442fb-e554-4013-a27a-a70f868887ac",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The document showcases positive clinical trial results for Imdusiran and AB-101.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented at EASL 2024. Includes stacked bar charts for threshold achievement and line chart for mean levels over 72 weeks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/16",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 13,
          "beatId": "a03442fb-e554-4013-a27a-a70f868887ac",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The document showcases positive clinical trial results for Imdusiran and AB-101.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented at EASL 2024. Includes pie charts comparing Group A and Group B across three metrics: time off NA therapy, HBV DNA levels, and HBsAg levels.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/17",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 13,
          "beatId": "a03442fb-e554-4013-a27a-a70f868887ac",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The document showcases positive clinical trial results for Imdusiran and AB-101.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a clinical trial structure with three cohorts (A, B, C) and a follow-up period, totaling 48 weeks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/18",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2202-715b-adea-57c1f9ae9ce5",
      "docSlug": "719db50244a96da2bbf79cc8f7d91684",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide details a specific licensing deal with financial terms and geographic scope.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2202-715b-adea-57c1f9ae9ce5/19",
      "deckHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5",
      "deckAnchorHref": "/decks/019de077-2202-715b-adea-57c1f9ae9ce5#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "preempt_rebuttal",
      "function": "preempt_rebuttal",
      "notes": "Uses a 'deal' framing to appeal to shareholder fairness and fiduciary consistency.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/20",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "preempt_rebuttal",
      "function": "preempt_rebuttal",
      "notes": "Uses a before-after framing to address shareholder concerns.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/21",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "closing_ask",
      "function": "closing_ask",
      "notes": "The slide uses a dark, high-contrast aesthetic typical of Tesla's corporate communications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/22",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/23",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "nominee_bio",
      "function": "introduce_nominees",
      "notes": "This slide is part of a defense strategy to preemptively rebut concerns about board independence.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/24",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "appendix_disclosure",
      "function": "analyze_data",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/25",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "closing_ask",
      "function": "closing_ask",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/26",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/27",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/28",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "other",
      "function": "front_matter",
      "notes": "This is a web page screenshot acting as a navigation hub for investor materials.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/29",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-216b-71fb-99a5-e57891a0f27d",
      "docSlug": "283a5ec38f7f33c6a622048aa48bdda9",
      "documentTitle": "Tesla | Shareholder Engagement Presentation Deck | 30 slides",
      "authorId": "tesla",
      "authorName": "Tesla",
      "documentKindSlug": "shareholder-letter",
      "documentKindLabel": "Shareholder letter",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "cite_precedent",
      "function": "cite_precedent",
      "notes": "The slide consists of a tweet by whatsupfranks and a reply by Elon Musk.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-216b-71fb-99a5-e57891a0f27d/30",
      "deckHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d",
      "deckAnchorHref": "/decks/019de077-216b-71fb-99a5-e57891a0f27d#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 22,
          "beatId": "efff3548-8480-402a-8753-fe11d31d5384",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck ends with a clear call to action, asking stockholders to vote for proposals three and four.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}